{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T04:17:41Z","timestamp":1792210661215,"version":"4.4.0"},"reference-count":160,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.ando.2023.09.003","type":"journal-article","created":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T11:27:45Z","timestamp":1695209265000},"page":"2-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["French guidelines from the GTE, AFCE and ENDOCAN-RENATEN (Groupe d\u2019\u00e9tude des Tumeurs Endocrines\/Association Francophone de Chirurgie Endocrinienne\/Reseau national de prise en charge des tumeurs endocrines) for the screening, diagnosis and management of Multiple Endocrine Neoplasia Type 1"],"prefix":"10.1016","volume":"85","author":[{"given":"Pierre","family":"Goudet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Cadiot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Barlier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Baudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Borson-Chazot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Brunaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Caiazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Cardot-Bauters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Castinetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Chanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Cuny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Dansin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Gaujoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Giraud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Groussin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u00eblle","family":"Le Bras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Lifante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel","family":"Mathonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"de Mestier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Miralli\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Pattou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Romanet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Sebag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Tresallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Vezzosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Tabarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2023.09.003_bib0805","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0002-9343(54)90353-8","article-title":"Genetic aspects of adenomatosis of endocrine glands","volume":"16","author":"Wermer","year":"1954","journal-title":"Am J Med"},{"key":"10.1016\/j.ando.2023.09.003_bib0810","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","article-title":"Guidelines for diagnosis and therapy of MEN type 1 and type 2","volume":"86","author":"Brandi","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.09.003_bib0815","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1056\/NEJMc1406028","article-title":"Breast-cancer predisposition in multiple endocrine neoplasia type 1","volume":"371","author":"Dreijerink","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2023.09.003_bib0820","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","volume":"97","author":"Thakker","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.09.003_bib0825","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1126\/science.276.5311.404","article-title":"Positional cloning of the gene for multiple endocrine neoplasia-type 1","volume":"276","author":"Chandrasekharappa","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.ando.2023.09.003_bib0830","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-17-0199","article-title":"The future: genetics advances in MEN1 therapeutic approaches and management strategies","volume":"24","author":"Agarwal","year":"2017","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ando.2023.09.003_bib0835","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1093\/bjs\/znac006","article-title":"Life expectancy and likelihood of surgery in multiple endocrine neoplasia type 1: AFCE and GTE cohort study","volume":"109","author":"Gaujoux","year":"2022","journal-title":"Br J Surg"},{"key":"10.1016\/j.ando.2023.09.003_bib0840","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00268-009-0290-1","article-title":"Risk factors and causes of death in MEN1 disease, A GTE (Groupe d\u2019\u00e9tude des tumeurs endocrines) cohort study among 758 patients","volume":"34","author":"Goudet","year":"2010","journal-title":"World J Surg"},{"key":"10.1016\/j.ando.2023.09.003_bib0845","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/MD.0b013e3182954af1","article-title":"Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1\/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors","volume":"92","author":"Ito","year":"2013","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ando.2023.09.003_bib0850","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1530\/EJE-12-0763","article-title":"Genetic analysis in young patients with sporadic pituitary macroadenomas: besides AIP don\u2019t forget MEN1 genetic analysis","volume":"168","author":"Cuny","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2023.09.003_bib0855","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1001\/archderm.1997.03890430067009","article-title":"Multiple facial angiofibromas and collagenomas in patients with multiple endocrine neoplasia type 1","volume":"133","author":"Darling","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ando.2023.09.003_bib0860","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1210\/jc.2018-01170","article-title":"UMD-MEN1 database: an overview of the 370 MEN1 variants present in 1676 patients from the French Population","volume":"104","author":"Romanet","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.09.003_bib0865","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12916-016-0708-1","article-title":"MEN1 redefined, a clinical comparison of mutation positive and mutation-negative patients","volume":"14","author":"de Laat","year":"2016","journal-title":"BMC Med"},{"key":"10.1016\/j.ando.2023.09.003_bib0870","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.surg.2020.04.067","article-title":"Understanding the clinical course of genotype-negative MEN1 patients can inform management strategies","volume":"169","author":"Pieterman","year":"2021","journal-title":"Surgery"},{"key":"10.1016\/j.ando.2023.09.003_bib0875","doi-asserted-by":"crossref","first-page":"E1089","DOI":"10.1002\/humu.21170","article-title":"Diagnostic challenges due to phenocopies: lessons from Multiple Endocrine Neoplasia type1 (MEN1)","volume":"31","author":"Turner","year":"2010","journal-title":"Hum Mutat"},{"key":"10.1016\/j.ando.2023.09.003_bib0880","doi-asserted-by":"crossref","first-page":"K1","DOI":"10.1530\/EJE-22-0171","article-title":"Multiple endocrine neoplasia type 1 caused by mosaic mutation: clinical follow-up and genetic counseling?","volume":"187","author":"Coppin","year":"2022","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2023.09.003_bib0885","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1359\/jbmr.090304","article-title":"Sporadic and MEN1-related primary hyperparathyroidism: differences in clinical expression and severity","volume":"24","author":"Eller-Vainicher","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ando.2023.09.003_bib0890","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/archsurg.134.10.1119","article-title":"Osteoporosis in multiple endocrine neoplasia type 1: severity, clinical significance, relationship to primary hyperparathyroidism, and response to parathyroidectomy","volume":"134","author":"Burgess","year":"1999","journal-title":"Arch Surg"},{"key":"10.1016\/j.ando.2023.09.003_bib0895","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1002\/jbmr.125","article-title":"Early-onset, progressive, frequent, extensive, and severe bone mineral and renal complications in multiple endocrine neoplasia type 1-associated primary hyperparathyroidism","volume":"25","author":"Louren\u00e7o","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ando.2023.09.003_bib0900","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1007\/s12325-021-01787-7","article-title":"Risk of cardiovascular conditions in patients with chronic hypoparathyroidism: a retrospective cohort study","volume":"38","author":"Gosmanova","year":"2021","journal-title":"Adv Ther"},{"key":"10.1016\/j.ando.2023.09.003_bib0905","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/cen.14067","article-title":"Paediatric and young adult manifestations and outcomes of multiple endocrine neoplasia type 1","volume":"91","author":"Herath","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2023.09.003_bib0910","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1210\/jc.2014-3659","article-title":"MEN1 disease occurring before 21 years old: a 160-patient cohort study from the Groupe d\u2019\u00e9tude des tumeurs endocrines","volume":"100","author":"Goudet","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.09.003_bib0915","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1007\/s00268-011-1068-9","article-title":"The optimal surgical treatment for primary hyperparathyroidism in MEN1 patients: a systematic review","volume":"35","author":"Schreinemakers","year":"2011","journal-title":"World J Surg"},{"key":"10.1016\/j.ando.2023.09.003_bib0920","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1097\/SLA.0b013e31824c5145","article-title":"Primary hyperparathyroidism in MEN1 patients: a cohort study with long-term follow-up on preferred surgical procedure and the relation with genotype","volume":"255","author":"Pieterman","year":"2012","journal-title":"Ann Surg"},{"key":"10.1016\/j.ando.2023.09.003_bib0925","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.surg.2014.08.006","article-title":"A randomized, prospective trial of operative treatments for hyperparathyroidism in patients with multiple endocrine neoplasia type 1","volume":"156","author":"Lairmore","year":"2014","journal-title":"Surgery"},{"key":"10.1016\/j.ando.2023.09.003_bib0930","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.surg.2017.07.023","article-title":"Disease and treatment factors associated with lower quality of life scores in adults with multiple endocrine neoplasia type I","volume":"162","author":"Goswami","year":"2017","journal-title":"Surgery"},{"key":"10.1016\/j.ando.2023.09.003_bib0935","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1007\/s12325-021-01649-2","article-title":"Risk of nephrolithiasis and nephrocalcinosis in patients with chronic hypoparathyroidism: a retrospective cohort study","volume":"38","author":"Ketteler","year":"2021","journal-title":"Adv Ther"},{"key":"10.1016\/j.ando.2023.09.003_bib0940","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.surg.2010.07.037","article-title":"Recurrent hyperparathyroidism and forearm parathyromatosis after total parathyroidectomy","volume":"148","author":"Melck","year":"2010","journal-title":"Surgery"},{"key":"10.1016\/j.ando.2023.09.003_bib0945","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1007\/s00268-016-3624-9","article-title":"Unilateral clearance for primary hyperparathyroidism in selected patients with multiple endocrine neoplasia type 1","volume":"40","author":"Kluijfhout","year":"2016","journal-title":"World J Surg"},{"key":"10.1016\/j.ando.2023.09.003_bib0950","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/cen.14112","article-title":"Single gland excision for MEN1-associated primary hyperparathyroidism","volume":"92","author":"Manoharan","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2023.09.003_bib0955","doi-asserted-by":"crossref","first-page":"e18681","DOI":"10.1097\/MD.0000000000018681","article-title":"Added value of 18F-fluorocholine positron emission tomography-computed tomography in presurgical localization of hyperfunctioning parathyroid glands after dual tracer subtraction scintigraphy failure: a retrospective study of 47 patients","volume":"99","author":"Morland","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ando.2023.09.003_bib0960","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1007\/s00268-020-05695-9","article-title":"18F-fluorocholine PET\/CT in MEN1 patients with primary hyperparathyroidism","volume":"44","author":"Gauth\u00e9","year":"2020","journal-title":"World J Surg"},{"key":"10.1016\/j.ando.2023.09.003_bib0965","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/01.md.0000112297.72510.32","article-title":"Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: a prospective study of 107 cases and comparison with 1009 cases from the literature","volume":"83","author":"Gibril","year":"2004","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ando.2023.09.003_bib0970","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s12020-015-0696-5","article-title":"Cinacalcet therapy in patients affected by primary hyperparathyroidism associated to Multiple Endocrine Neoplasia Syndrome type 1 (MEN1)","volume":"52","author":"Giusti","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.ando.2023.09.003_bib0975","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3389\/fendo.2018.00597","article-title":"When parathyroidectomy should be indicated or postponed in adolescents with MEN1-related primary hyperparathyroidism","volume":"9","author":"Marini","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ando.2023.09.003_bib0980","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1097\/SLA.0b013e31811f4467","article-title":"Is total parathyroidectomy the treatment of choice for hyperparathyroidism in multiple endocrine neoplasia type 1?","volume":"246","author":"Tonelli","year":"2007","journal-title":"Ann Surg"},{"key":"10.1016\/j.ando.2023.09.003_bib0985","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1007\/s00268-017-4366-z","article-title":"Impact of \u201ctailored\u201d parathyroidectomy for treatment of primary hyperparathyroidism in patients with multiple endocrine neoplasia type 1","volume":"42","author":"Horiuchi","year":"2018","journal-title":"World J Surg"},{"key":"10.1016\/j.ando.2023.09.003_bib0990","doi-asserted-by":"crossref","first-page":"110482","DOI":"10.1016\/j.mehy.2020.110482","article-title":"Why is primary hyperparathyroidism more severe in children?","volume":"147","author":"McKenna","year":"2021","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.ando.2023.09.003_bib0995","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S1043-2760(00)00336-2","article-title":"Acquisition of optimal bone mass in childhood and adolescence","volume":"12","author":"Bachrach","year":"2001","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.09.003_bib1000","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-17-0231","article-title":"The future: diagnostic and imaging advances in MEN1 therapeutic approaches and management strategies","volume":"24","author":"Manoharan","year":"2017","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ando.2023.09.003_bib1005","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41574-021-00468-3","article-title":"Clinical aspects of multiple endocrine neoplasia type 1","volume":"17","author":"Al-Salameh","year":"2021","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.ando.2023.09.003_bib1010","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.dld.2011.09.014","article-title":"Magnetic resonance imaging versus endoscopic ultrasonography for the detection of pancreatic tumours in multiple endocrine neoplasia type 1","volume":"44","author":"Barbe","year":"2012","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.ando.2023.09.003_bib1015","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.gie.2014.09.037","article-title":"EUS is superior for detection of pancreatic lesions compared with standard imaging in patients with multiple endocrine neoplasia type 1","volume":"81","author":"van Asselt","year":"2015","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.ando.2023.09.003_bib1020","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1530\/EJE-14-0878","article-title":"Long-term results of the surgical management of insulinoma patients with MEN1: a Groupe d\u2019\u00e9tude des tumeurs endocrines (GTE) retrospective study","volume":"172","author":"Vezzosi","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2023.09.003_bib1025","doi-asserted-by":"crossref","first-page":"E89","DOI":"10.1210\/jc.2013-1768","article-title":"Penetrance of functioning and nonfunctioning pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 in the second decade of life","volume":"99","author":"Gon\u00e7alves","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.09.003_bib1030","doi-asserted-by":"crossref","first-page":"5495","DOI":"10.3748\/wjg.v18.i39.5495","article-title":"Diagnosis of Zollinger-Ellison syndrome: increasingly difficult","volume":"18","author":"Ito","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ando.2023.09.003_bib1035","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1097\/SLA.0000000000003162","article-title":"Metastatic potential and survival of duodenal and pancreatic tumors in multiple endocrine neoplasia type 1: A GTE and AFCE Cohort Study (Groupe d\u2019\u00e9tude des tumeurs endocrines and Association francophone de chirurgie endocrinienne)","volume":"272","author":"Vinault","year":"2020","journal-title":"Ann Surg"},{"key":"10.1016\/j.ando.2023.09.003_bib1040","unstructured":"TNCD. Th\u00e9saurus national de canc\u00e9rologie digestive. https:\/\/www.snfge.org\/tncd."},{"key":"10.1016\/j.ando.2023.09.003_bib1045","first-page":"63","article-title":"Management of pancreatic neuroendocrine tumors in patients with MEN 1","volume":"4","author":"Sadowski","year":"2015","journal-title":"Gland Surg"},{"key":"10.1016\/j.ando.2023.09.003_bib1050","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1007\/s00259-016-3319-3","article-title":"Evaluation of (68)Ga-DOTA-TOC PET\/CT for the detection of duodenopancreatic neuroendocrine tumors in patients with MEN1","volume":"43","author":"Morgat","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ando.2023.09.003_bib1055","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1159\/000511791","article-title":"Multiple endocrine neoplasia type 1 and the pancreas: diagnosis and treatment of functioning and non-functioning pancreatic and duodenal neuroendocrine neoplasia within the MEN1 Syndrome - An International Consensus Statement","volume":"111","author":"Niederle","year":"2021","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.ando.2023.09.003_bib1060","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1572-0241.2006.00367.x","article-title":"Prospective endoscopic ultrasonographic evaluation of the frequency of nonfunctioning pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1","volume":"101","author":"Thomas-Marques","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ando.2023.09.003_bib1065","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/01.sla.0000197715.96762.68","article-title":"Epidemiology data on 108 MEN 1 patients from the GTE with isolated nonfunctioning tumors of the pancreas","volume":"243","author":"Triponez","year":"2006","journal-title":"Ann Surg"},{"key":"10.1016\/j.ando.2023.09.003_bib1070","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1007\/s00268-005-0354-9","article-title":"Is surgery beneficial for MEN1 patients with small (< or=2cm), nonfunctioning pancreaticoduodenal endocrine tumor? An analysis of 65 patients from the GTE","volume":"30","author":"Triponez","year":"2006","journal-title":"World J Surg"},{"key":"10.1016\/j.ando.2023.09.003_bib1075","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/SLA.0000000000002191","article-title":"Long-term follow-up of MEN1 patients who do not have initial surgery for small \u22642cm nonfunctioning pancreatic neuroendocrine tumors, an AFCE and GTE Study: Association francophone de chirurgie endocrinienne & Groupe d\u2019\u00e9tude des tumeurs endocrines","volume":"268","author":"Triponez","year":"2018","journal-title":"Ann Surg"},{"key":"10.1016\/j.ando.2023.09.003_bib1080","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1210\/js.2018-00087","article-title":"Diagnosing nonfunctional pancreatic NETs in MEN1: the evidence base","volume":"2","author":"van Treijen","year":"2018","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.ando.2023.09.003_bib1085","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s40618-017-0783-y","article-title":"Expression of p27Kip1 and p18Ink4c in human multiple endocrine neoplasia type 1-related pancreatic neuroendocrine tumors","volume":"41","author":"Conemans","year":"2018","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.ando.2023.09.003_bib1090","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/s12020-015-0702-y","article-title":"Role of (68)Ga-DOTATATE PET\/CT in patients with multiple endocrine neoplasia type 1 (MEN1)","volume":"52","author":"Lastoria","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.ando.2023.09.003_bib1095","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1210\/jc.2016-3865","article-title":"Utility of FDG-PET imaging for risk stratification of pancreatic neuroendocrine tumors in MEN1","volume":"102","author":"Kornaczewski Jackson","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.09.003_bib1100","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000105810","article-title":"Endocrine precursor lesions and microadenomas of the duodenum and pancreas with and without MEN1: criteria, molecular concepts and clinical significance","volume":"74","author":"Anlauf","year":"2007","journal-title":"Pathobiology"},{"key":"10.1016\/j.ando.2023.09.003_bib1105","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1053\/j.gastro.2005.01.058","article-title":"Precursor lesions in patients with multiple endocrine neoplasia type 1-associated duodenal gastrinomas","volume":"128","author":"Anlauf","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ando.2023.09.003_bib1110","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S2213-8587(15)00043-1","article-title":"Challenges and controversies in management of pancreatic neuroendocrine tumours in patients with MEN1","volume":"3","author":"Yates","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.ando.2023.09.003_bib1115","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2217\/ije-2017-0018","article-title":"Diagnosis of Zollinger-Ellison syndrome in the era of PPIs, faulty gastrin assays, sensitive imaging and limited access to acid secretory testing","volume":"4","author":"Metz","year":"2017","journal-title":"Int J Endocr Oncol"},{"key":"10.1016\/j.ando.2023.09.003_bib1120","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/MPA.0b013e318298df75","article-title":"Secretin stimulation test for gastrin release in Zollinger-Ellison syndrome: to do or not to do?","volume":"42","author":"Poitras","year":"2013","journal-title":"Pancreas"},{"key":"10.1016\/j.ando.2023.09.003_bib1125","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.anchir.2003.11.013","article-title":"Gastrinomas in multiple endocrine neoplasia type-1. A 127-case cohort study from the endocrine tumor group (ETG)","volume":"129","author":"Goudet","year":"2004","journal-title":"Ann Chir"},{"key":"10.1016\/j.ando.2023.09.003_bib1130","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1530\/EJE-10-0950","article-title":"Gender-related differences in MEN1 lesion occurrence and diagnosis: a cohort study of 734 cases from the Groupe d\u2019\u00e9tude des tumeurs endocrines","volume":"165","author":"Goudet","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2023.09.003_bib1135","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1002\/jso.25667","article-title":"Prognostic factors and survival in MEN1 patients with gastrinomas: results from the DutchMEN study group (DMSG)","volume":"120","author":"van Beek","year":"2019","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ando.2023.09.003_bib1140","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1136\/gut.33.9.1275","article-title":"Influence of multiple endocrine neoplasia type 1 on gastric endocrine cells in patients with the Zollinger-Ellison syndrome","volume":"33","author":"Lehy","year":"1992","journal-title":"Gut"},{"key":"10.1016\/j.ando.2023.09.003_bib1145","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1210\/jc.2007-2279","article-title":"A prospective study of gastric carcinoids and Enterochromaffin-like cell changes in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: identification of risk factors","volume":"93","author":"Berna","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.09.003_bib1150","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000443168","article-title":"ENETS Consensus Guidelines update for gastroduodenal neuroendocrine neoplasms","volume":"103","author":"Delle Fave","year":"2016","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.ando.2023.09.003_bib1155","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1007\/s00268-009-9983-8","article-title":"Screening of patients with multiple endocrine neoplasia type 1 (MEN-1): a critical analysis of its value","volume":"33","author":"Waldmann","year":"2009","journal-title":"World J Surg"},{"key":"10.1016\/j.ando.2023.09.003_bib1160","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1365-2265.2011.04227.x","article-title":"Multiple endocrine neoplasia type 1 in Japan: establishment and analysis of a multicentre database","volume":"76","author":"Sakurai","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2023.09.003_bib1165","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1002\/bjs.11632","article-title":"Surgery for multiple endocrine neoplasia type 1-related insulinoma: long-term outcomes in a large international cohort","volume":"107","author":"van Beek","year":"2020","journal-title":"Br J Surg"},{"key":"10.1016\/j.ando.2023.09.003_bib1170","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1210\/jc.2008-2031","article-title":"Secular trends in the presentation and management of functioning insulinoma at the Mayo Clinic, 1987\u20132007","volume":"94","author":"Placzkowski","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.09.003_bib1175","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1210\/jc.2008-1410","article-title":"Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline","volume":"94","author":"Cryer","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.09.003_bib1180","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ando.2013.05.003","article-title":"French Endocrine Society. Fast test: clinical practice and interpretation","volume":"74","author":"Agin","year":"2013","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.ando.2023.09.003_bib1185","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1210\/jcem.85.9.6807","article-title":"Forty-eight-hour fast: the diagnostic test for insulinoma","volume":"85","author":"Hirshberg","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.09.003_bib1190","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1067\/msy.1998.93107","article-title":"The variable penetrance and spectrum of manifestations of multiple endocrine neoplasia type 1","volume":"124","author":"Carty","year":"1998","journal-title":"Surgery"},{"key":"10.1016\/j.ando.2023.09.003_bib1195","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1148\/radiology.178.1.1984311","article-title":"Insulinomas: localization with selective intraarterial injection of calcium","volume":"178","author":"Doppman","year":"1991","journal-title":"Radiology"},{"key":"10.1016\/j.ando.2023.09.003_bib1200","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2967\/jnumed.115.167445","article-title":"Glucagon-like peptide-1 receptor PET\/CT with 68Ga-NOTA-Exendin-4 for detecting localized insulinoma: a prospective cohort study","volume":"57","author":"Luo","year":"2016","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ando.2023.09.003_bib1205","doi-asserted-by":"crossref","first-page":"5843","DOI":"10.1210\/jc.2018-02754","article-title":"68Ga-Exendin-4 PET\/CT detects insulinomas in patients with endogenous hyperinsulinemic hypoglycemia in MEN-1","volume":"104","author":"Antwi","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.09.003_bib1210","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/cen.14406","article-title":"Exendin-4-based imaging in insulinoma localization: systematic review and meta-analysis","volume":"95","author":"Shah","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2023.09.003_bib1215","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3389\/fendo.2012.00158","article-title":"Glucagon-like peptide-1 receptor overexpression in cancer and its impact on clinical applications","volume":"3","author":"K\u00f6rner","year":"2012","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ando.2023.09.003_bib1220","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0399-8320(04)95184-6","article-title":"Prevalence, characteristics and prognosis of MEN 1-associated glucagonomas, VIPomas, and somatostatinomas: study from the GTE (Groupe des tumeurs endocrines) registry","volume":"28","author":"L\u00e9vy-Bohbot","year":"2004","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.ando.2023.09.003_bib1225","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000335591","article-title":"ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes","volume":"95","author":"Jensen","year":"2012","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.ando.2023.09.003_bib1230","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1159\/000510514","article-title":"Reliability and agreement of radiological and pathological tumor size in patients with multiple endocrine neoplasia type 1-related pancreatic neuroendocrine tumors: results from a population-based cohort","volume":"111","author":"van Beek","year":"2021","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.ando.2023.09.003_bib1235","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1210\/jc.2013-1800","article-title":"Low accuracy of tumor markers for diagnosing pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 patients","volume":"98","author":"de Laat","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.09.003_bib1240","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/cen.13119","article-title":"Utility of chromogranin A, pancreatic polypeptide, glucagon and gastrin in the diagnosis and follow-up of pancreatic neuroendocrine tumours in multiple endocrine neoplasia type 1 patients","volume":"85","author":"Qiu","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2023.09.003_bib1245","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1677\/erc.1.01220","article-title":"Natural course of small, asymptomatic neuroendocrine pancreatic tumours in multiple endocrine neoplasia type 1: an endoscopic ultrasound imaging study","volume":"13","author":"Kann","year":"2006","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ando.2023.09.003_bib1250","first-page":"27","article-title":"Growth rate of small pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: results from an endoscopic ultrasound based cohort study","volume":"49","author":"Kappelle","year":"2017","journal-title":"Endoscopy"},{"key":"10.1016\/j.ando.2023.09.003_bib1255","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/01.sla.0000189549.51913.d8","article-title":"Outcome of duodenopancreatic resections in patients with multiple endocrine neoplasia type 1","volume":"242","author":"Bartsch","year":"2005","journal-title":"Ann Surg"},{"key":"10.1016\/j.ando.2023.09.003_bib1260","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.3748\/wjg.v17.i10.1343","article-title":"Biochemically curative surgery for gastrinoma in multiple endocrine neoplasia type 1 patients","volume":"17","author":"Imamura","year":"2011","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ando.2023.09.003_bib1265","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.surg.2011.09.028","article-title":"Achieving eugastrinemia in MEN1 patients: both duodenal inspection and formal lymph node dissection are important","volume":"150","author":"Dickson","year":"2011","journal-title":"Surgery"},{"key":"10.1016\/j.ando.2023.09.003_bib1270","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s00268-016-3456-7","article-title":"Minimally invasive versus open pancreatic surgery in patients with multiple endocrine neoplasia type 1","volume":"40","author":"Lopez","year":"2016","journal-title":"World J Surg"},{"key":"10.1016\/j.ando.2023.09.003_bib1275","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1046\/j.1365-2796.1998.00307.x","article-title":"Current concepts in the surgical management of multiple endocrine neoplasia type 1 pancreatic-duodenal disease. Results in the treatment of 40 patients with Zollinger-Ellison syndrome, hypoglycaemia or both","volume":"243","author":"Thompson","year":"1998","journal-title":"J Intern Med"},{"key":"10.1016\/j.ando.2023.09.003_bib1280","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/01.sla.0000143252.02142.3e","article-title":"Resolved and unresolved controversies in the surgical management of patients with Zollinger-Ellison syndrome","volume":"240","author":"Norton","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.ando.2023.09.003_bib1285","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/01.sla.0000218073.77254.62","article-title":"Pancreatectomy in multiple endocrine neoplasia type 1-related gastrinomas and pancreatic endocrine neoplasias","volume":"244","author":"Tonelli","year":"2006","journal-title":"Ann Surg"},{"key":"10.1016\/j.ando.2023.09.003_bib1290","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1007\/s00268-021-06005-7","article-title":"Pancreatoduodenectomy for neuroendocrine tumors in patients with multiple endocrine neoplasia type 1: an AFCE (Association Francophone de Chirurgie Endocrinienne) and GTE (Groupe d\u2019\u00e9tude des tumeurs endocrines) Study","volume":"45","author":"Santucci","year":"2021","journal-title":"World J Surg"},{"key":"10.1016\/j.ando.2023.09.003_bib1295","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.pan.2020.12.002","article-title":"Total gastrectomy for severe proton pump inhibitor-induced hypomagnesemia in a MEN1\/Zollinger Ellison syndrome patient","volume":"21","author":"Perrier","year":"2021","journal-title":"Pancreatology"},{"issue":"Suppl. 1","key":"10.1016\/j.ando.2023.09.003_bib1300","doi-asserted-by":"crossref","first-page":"173","DOI":"10.6061\/clinics\/2012(Sup01)29","article-title":"Surgical management of pancreatico-duodenal tumors in multiple endocrine neoplasia syndrome type 1","volume":"67","author":"Akerstr\u00f6m","year":"2012","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.ando.2023.09.003_bib1305","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/s12020-015-0702-y","article-title":"Role of (68)Ga-DOTATATE PET\/CT in patients with multiple endocrine neoplasia type 1 (MEN1)","volume":"52","author":"Lastoria","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.ando.2023.09.003_bib1310","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.dld.2020.09.001","article-title":"Clinical usefulness of FDG-PET for management of well-differentiated digestive neuroendocrine tumors","volume":"52","author":"Perrier","year":"2020","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.ando.2023.09.003_bib1315","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1016\/j.cgh.2023.02.022","article-title":"Endoscopic ultrasound-guided radiofrequency ablation versus surgical resection for treatment of pancreatic insulinoma","volume":"21","author":"Crin\u00f2","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ando.2023.09.003_bib1320","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.gie.2023.04.003","article-title":"Risk factors for endoscopic ultrasound-guided radiofrequency ablation adverse events in patients with pancreatic neoplasms: a large national French study (RAFPAN study)","volume":"98","author":"Napol\u00e9on","year":"2023","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.ando.2023.09.003_bib1325","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.pan.2019.12.017","article-title":"Occult insulinoma, glucagonoma and pancreatic endocrine pseudotumour in a patient with multiple endocrine neoplasia type 1","volume":"20","author":"Erichsen","year":"2020","journal-title":"Pancreatology"},{"key":"10.1016\/j.ando.2023.09.003_bib1330","first-page":"e8208","article-title":"Imaging and diagnostic challenges in a patient with refractory hypoglycemia caused by insulinomas related to multiple endocrine neoplasia type 1","volume":"12","author":"Nance","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.ando.2023.09.003_bib1335","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/jso.24315","article-title":"Robot-assisted spleen preserving panceatic surgery in MEN1 patients","volume":"114","author":"Nell","year":"2016","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ando.2023.09.003_bib1340","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1210\/jc.2019-00282","article-title":"Endoscopic ultrasound-guided radiofrequency ablation: a new therapeutic approach for pancreatic neuroendocrine tumors","volume":"104","author":"Oleinikov","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.09.003_bib1345","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1210\/JC.2015-2015","article-title":"Long-term natural course of pituitary tumors in patients with MEN1: results from the DutchMEN1 Study Group (DMSG)","volume":"100","author":"de Laat","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.09.003_bib1350","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s12020-017-1234-4","article-title":"Multiple endocrine neoplasia syndrome type 1: institution, management, and data analysis of a nationwide multicenter patient database","volume":"58","author":"Giusti","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/j.ando.2023.09.003_bib1355","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11102-019-00939-x","article-title":"Pituitary adenomas in patients with multiple endocrine neoplasia type 1: a single-center experience in China","volume":"22","author":"Wu","year":"2019","journal-title":"Pituitary"},{"key":"10.1016\/j.ando.2023.09.003_bib1360","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1530\/EJE-21-0630","article-title":"Pituitary adenoma in patients with multiple endocrine neoplasia type 1: a cohort study","volume":"185","author":"Le Bras","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2023.09.003_bib1365","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1210\/jcem.87.2.8145","article-title":"Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study","volume":"87","author":"Verg\u00e8s","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.09.003_bib1370","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/PAS.0b013e31815ade45","article-title":"Groupe d\u2019\u00e9tudes des tumeurs endocrines Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients","volume":"32","author":"Trouillas","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ando.2023.09.003_bib1375","first-page":"4776","article-title":"Pituitary macroadenoma in a 5-year-old: an early expression of multiple endocrine neoplasia type 1","volume":"85","author":"Stratakis","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.09.003_bib1380","doi-asserted-by":"crossref","first-page":"dgaa257","DOI":"10.1210\/clinem\/dgaa257","article-title":"Clues for genetic anticipation in multiple endocrine neoplasia type 1","volume":"105","author":"van den Broek","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.09.003_bib1385","first-page":"2642","article-title":"Spectrum of pituitary disease in multiple endocrine neoplasia type 1 (MEN 1): clinical, biochemical, and radiological features of pituitary disease in a large MEN 1 kindred","volume":"81","author":"Burgess","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.09.003_bib1390","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1210\/jc.2004-1373","article-title":"Gonadotroph tumor associated with multiple endocrine neoplasia type 1","volume":"90","author":"Benito","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.09.003_bib1395","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1365-2265.2006.02697.x","article-title":"Metastatic prolactinoma presenting as a cervical spinal cord tumour in multiple endocrine neoplasia type one (MEN-1)","volume":"66","author":"Gordon","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2023.09.003_bib1400","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ando.2012.03.001","article-title":"Long-term control of a MEN1 prolactin secreting pituitary carcinoma after temozolomide treatment","volume":"73","author":"Philippon","year":"2012","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.ando.2023.09.003_bib1405","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.humpath.2008.06.013","article-title":"Multiple endocrine neoplasia type 1-associated thyrotropin-producing pituitary carcinoma: report of a probable de novo example","volume":"40","author":"Scheithauer","year":"2009","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ando.2023.09.003_bib1410","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1530\/EJE-11-0679","article-title":"Adrenal involvement in MEN1. Analysis of 715 cases from the Groupe d\u2019\u00e9tude des tumeurs endocrines database","volume":"166","author":"Gatta-Cherifi","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2023.09.003_bib1415","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1530\/EJE-07-0635","article-title":"Natural course of small adrenal lesions in multiple endocrine neoplasia type 1: an endoscopic ultrasound imaging study","volume":"158","author":"Schaefer","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2023.09.003_bib1420","doi-asserted-by":"crossref","DOI":"10.1530\/EJE-16-0467","article-title":"Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors","volume":"175","author":"Fassnacht","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2023.09.003_bib1425","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1210\/clinem\/dgab512","article-title":"Approach to the patient with adrenal incidentaloma","volume":"106","author":"Bancos","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.09.003_bib1430","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1530\/EC-18-0526","article-title":"Adrenocortical carcinoma in patients with MEN1: a kindred report and review of the literature","volume":"8","author":"Wang","year":"2019","journal-title":"Endocr Connect"},{"key":"10.1016\/j.ando.2023.09.003_bib1435","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.bulcan.2023.03.015","article-title":"Guidelines of the French National ENDOCAN-COMETE, Association of Endocrine Surgery, Society of Urology for the management of adrenocortical carcinoma","volume":"110","author":"Lib\u00e9","year":"2023","journal-title":"Bull Cancer"},{"key":"10.1016\/j.ando.2023.09.003_bib1440","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1210\/jc.2014-1560","article-title":"Natural course and survival of neuroendocrine tumors of thymus and lung in MEN1 patients","volume":"99","author":"de Laat","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.09.003_bib1445","first-page":"e18590","article-title":"Cushing's Syndrome due to a functional thymic neuroendocrine tumor in multiple endocrine neoplasia type 1 syndrome","volume":"13","author":"Asemota","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.ando.2023.09.003_bib1450","doi-asserted-by":"crossref","first-page":"L15","DOI":"10.1530\/ERC-21-0226","article-title":"Two distinct classes of thymic tumors in patients with MEN1 show LOH at the MEN1 locus","volume":"28","author":"Mandl","year":"2021","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ando.2023.09.003_bib1455","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1210\/jc.2004-1155","article-title":"Thymic neuroendocrine carcinoma (carcinoid) in multiple endocrine neoplasiatype 1 syndrome: the Italian series","volume":"90","author":"Ferolla","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.09.003_bib1460","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s00268-009-9980-y","article-title":"Thymic neuroendocrine tumors in multiple endocrine neoplasia type 1: a comparative study on 21 cases among a series of 761 MEN1 from the GTE (Groupe des tumeurs endocrines)","volume":"33","author":"Goudet","year":"2009","journal-title":"World J Surg"},{"key":"10.1016\/j.ando.2023.09.003_bib1465","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12883-020-01659-7","article-title":"p.L105Vfs mutation in a family with thymic neuroendocrine tumor combined with MEN1: a case report","volume":"20","author":"Zheng","year":"2020","journal-title":"BMC Neurol"},{"key":"10.1016\/j.ando.2023.09.003_bib1470","doi-asserted-by":"crossref","first-page":"E125","DOI":"10.21037\/jtd.2018.01.127","article-title":"Clinical implication of MEN1 mutation on surgically resected thymic carcinoid patients","volume":"10","author":"Li","year":"2018","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.ando.2023.09.003_bib1475","series-title":"Les tumeurs thymiques neuroendocrines dans la n\u00e9oplasie endocrinienne multiple de type 1. Th\u00e8se de M\u00e9decine soutenue le 15-11-2021","author":"Mendes","year":"2021"},{"key":"10.1016\/j.ando.2023.09.003_bib1480","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s12672-015-0228-z","article-title":"Thymic and bronchial carcinoid tumors in multiple endocrine neoplasia type 1: the Mayo Clinic Experience from 1977 to 2013","volume":"6","author":"Ospina","year":"2015","journal-title":"Horm Cancer"},{"key":"10.1016\/j.ando.2023.09.003_bib1485","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s12672-016-0269-y","article-title":"Clinical features, treatments, and outcomes of patients with thymic carcinoids and multiple endocrine neoplasia Type 1 syndrome at MD Anderson cancer center","volume":"7","author":"Christakis","year":"2016","journal-title":"Horm Cancer"},{"key":"10.1016\/j.ando.2023.09.003_bib1490","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1210\/jc.2002-021314","article-title":"Prospective study of thymic carcinoids in patients with multiple endocrineneoplasia type 1","volume":"88","author":"Gibril","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.09.003_bib1495","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s12020-022-03099-4","article-title":"Thymic neuroendocrine tumors in patients with multiple endocrine neoplasiatype 1","volume":"77","author":"Yliaska","year":"2022","journal-title":"Endocrine"},{"key":"10.1016\/j.ando.2023.09.003_bib1500","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1159\/000526775","article-title":"Revisiting the evidence for routine transcervical thymectomy for the prevention of thymic carcinoid tumours in MEN-1 patients","volume":"100","author":"De Jong","year":"2022","journal-title":"Oncology"},{"key":"10.1016\/j.ando.2023.09.003_bib1505","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-17-0285","article-title":"The future: surgical advances in MEN1 therapeutic approaches and management strategies","volume":"24","author":"Sadowski","year":"2017","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ando.2023.09.003_bib1510","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.annonc.2021.01.003","article-title":"Lung and thymic carcinoids: ESMO Clinical Pracice Guidelines for diagnosis, treatment and follow-up","volume":"32","author":"Baudin","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ando.2023.09.003_bib1515","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13019-022-01847-1","article-title":"Single-incision port robot-assisted surgery for thymic carcinoid tumor resection","volume":"17","author":"Shidei","year":"2022","journal-title":"J Cardiothorac Surg"},{"key":"10.1016\/j.ando.2023.09.003_bib1520","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00268-017-4135-z","article-title":"Histologically proven bronchial neuroendocrine tumors in MEN1: a GTE 51-case cohort study","volume":"42","author":"Lecomte","year":"2018","journal-title":"World J Surg"},{"key":"10.1016\/j.ando.2023.09.003_bib1525","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/j.jtho.2021.07.020","article-title":"Well-differentiated bronchopulmonary neuroendocrine tumors: more than one entity","volume":"16","author":"van den Broek","year":"2021","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ando.2023.09.003_bib1530","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13550-022-00900-3","article-title":"Value of [68Ga]Ga-somatostatin receptor PET\/CT in the grading of pulmonary neuroendocrine (carcinoid) tumours and the detection of disseminated disease: single-centre pathology-based analysis and review of the literature","volume":"12","author":"Deleu","year":"2022","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.ando.2023.09.003_bib1535","first-page":"255","article-title":"Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities","volume":"1826","author":"Swarts","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ando.2023.09.003_bib1540","doi-asserted-by":"crossref","first-page":"5328","DOI":"10.1210\/jc.2004-0218","article-title":"Cutaneous tumors in patients with multiple endocrine neoplasm type 1 (MEN1) and gastrinomas: prospective study of frequency and development of criteria with high sensitivity and specificity for MEN1","volume":"89","author":"Asgharian","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.09.003_bib1545","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.3390\/diagnostics12112768","article-title":"Approach of multiple endocrine neoplasia type 1 (MEN1) syndrome-related skin tumors","volume":"12","author":"B\u0103icoianu-Ni\u021bescu","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.ando.2023.09.003_bib1550","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0002-9440(10)61788-9","article-title":"Multiple leiomyomas of the esophagus, lung, and uterus in multiple endocrine neoplasia type 1","volume":"159","author":"McKeeby","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ando.2023.09.003_bib1555","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1507\/endocrj.51.75","article-title":"Multiple endocrine neoplasia type 1 with unusual concomitance of various neoplastic disorders","volume":"51","author":"Nishimura","year":"2004","journal-title":"Endocr J"},{"key":"10.1016\/j.ando.2023.09.003_bib1560","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s12881-020-01129-4","article-title":"A novel mutation of the MEN1 gene in a patient with multiple endocrine neoplasia type 1 and recurrent fibromyxoid sarcoma - a case report","volume":"21","author":"Radman","year":"2020","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.ando.2023.09.003_bib1565","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1210\/jc.2018-00259","article-title":"High fear of disease occurrence is associated with low quality of life in patients with multiple endocrine neoplasia type 1: results from the Dutch MEN1 Study Group","volume":"103","author":"van Leeuwaarde","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.09.003_bib1570","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.surg.2017.04.030","article-title":"Health-related quality of life in MEN1 patients compared with other chronic conditions and the United States general population","volume":"163","author":"Peipert","year":"2018","journal-title":"Surgery"},{"key":"10.1016\/j.ando.2023.09.003_bib1575","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1023\/A:1023252107120","article-title":"Quality of life in patients with multiple endocrine neoplasia type 1 (MEN 1)","volume":"2","author":"Berglund","year":"2003","journal-title":"Fam Cancer"},{"key":"10.1016\/j.ando.2023.09.003_bib1580","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10897-006-9047-2","article-title":"Living with multiple endocrine neoplasia type 1: decent care-insufficient medical and genetic information: a qualitative study of MEN 1 patients in a Swedish hospital","volume":"16","author":"Str\u00f8msvik","year":"2007","journal-title":"J Genet Couns"},{"key":"10.1016\/j.ando.2023.09.003_bib1585","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13023-020-01650-y","article-title":"Quality of life in Italian patients with multiple endocrine neoplasia type 1 (MEN 1): results of an extensive survey","volume":"16","author":"Giusti","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.ando.2023.09.003_bib1590","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.surg.2007.09.010","article-title":"Pancreatoduodenal surgery in patients with multiple endocrine neoplasia type 1: operative outcomes, long-term function, and quality of life","volume":"142","author":"You","year":"2007","journal-title":"Surgery"},{"key":"10.1016\/j.ando.2023.09.003_bib1595","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.surg.2017.07.010","article-title":"Financial burden is associated with worse health-related quality of life in adults with multiple endocrine neoplasia type 1","volume":"162","author":"Peipert","year":"2017","journal-title":"Surgery"},{"key":"10.1016\/j.ando.2023.09.003_bib1600","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1007\/s002680010237","article-title":"Are patients with multiple endocrine neoplasia type I prone to premature death?","volume":"24","author":"Dean","year":"2000","journal-title":"World J Surg"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426623007072?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426623007072?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T11:46:09Z","timestamp":1727178369000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426623007072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":160,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0003426623007072"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2023.09.003","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"French guidelines from the GTE, AFCE and ENDOCAN-RENATEN (Groupe d\u2019\u00e9tude des Tumeurs Endocrines\/Association Francophone de Chirurgie Endocrinienne\/Reseau national de prise en charge des tumeurs endocrines) for the screening, diagnosis and management of Multiple Endocrine Neoplasia Type 1","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2023.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}